Page last updated: 2024-12-07

15,16-dihydrocyclopenta(a)phenanthren-17-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

15,16-dihydrocyclopenta(a)phenanthren-17-one is a **synthetic steroid** with a chemical structure closely related to the naturally occurring steroid **estradiol**.

Here's why it's important for research:

* **Understanding Estrogen Receptor Function:** 15,16-dihydrocyclopenta(a)phenanthren-17-one can be used to study the **mechanism of action of estrogen receptors** (ERs). These receptors play crucial roles in various physiological processes like sexual development, reproduction, and bone metabolism. By investigating how this synthetic steroid interacts with ERs, researchers gain insights into the structure and function of these receptors.

* **Developing New Drugs:** 15,16-dihydrocyclopenta(a)phenanthren-17-one has been studied as a potential **therapeutic agent for conditions influenced by estrogen levels**. Examples include:
* **Hormone Replacement Therapy (HRT):** It could potentially be used to treat symptoms of menopause or other hormonal imbalances.
* **Cancer Treatment:** Research explores its potential as an anti-cancer agent, particularly in breast cancer where estrogen signaling is often involved.
* **Bone Health:** Its effects on bone density and metabolism are investigated for potential applications in osteoporosis.

* **Exploring Structural-Activity Relationships:** Comparing the activity of this compound with that of other steroids helps researchers understand the **structural features required for specific biological actions**. This knowledge can be used to design new, more potent, or more selective steroid-based drugs.

**However, it's important to note that:**

* While 15,16-dihydrocyclopenta(a)phenanthren-17-one holds potential as a drug, it is **not currently used clinically**. Its effectiveness and safety need to be further investigated.
* Steroids can have **significant side effects** depending on their structure, dosage, and the individual's health condition.

Overall, 15,16-dihydrocyclopenta(a)phenanthren-17-one serves as a valuable tool in research focused on understanding estrogen receptor function, developing new drugs, and exploring the relationship between steroid structure and activity.

15,16-dihydrocyclopenta(a)phenanthren-17-one: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107708
SCHEMBL ID9576677
MeSH IDM0058326

Synonyms (14)

Synonym
17h-cyclopenta(a)phenanthren-17-one, 15,16-dihydro-
15,16-dihydrocyclopenta(a)phenanthren-17-one
15,16-dihydro-17h-cyclopenta(a)phenanthren-17-one
brn 2052489
ccris 6654
15,16-dihydrocyclopenta[a]phenanthren-17-one
gona-1,3,5,7,9,11,13-heptaen-17-one
4-07-00-01789 (beilstein handbook reference)
786-66-3
niosh/gy5710500
15h-cyclopenta(a)phenanthren-17(16h)-one
GY57105000
DTXSID10229200
SCHEMBL9576677
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.67 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]